Experts analyze damages based on reasonable royalty for use of infringing materials
Jeffrey Brown and Amit Bubna led a Bates White team working on behalf of Regenxbio in patent litigation against Aldevron. Regenxbio alleged that Aldevron manufactured cultured host cells to replicate plasmid DNA used to package genes for gene therapy applications. The expert reports analyzed damages based on a reasonable royalty for use of infringing materials in product development and clinical trials. The parties reached a pre-trial settlement.